{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-002132","form_type":"8-K","ticker":"PLSH","cik":"0001552189","company_name":"PANACEA LIFE SCIENCES HOLDINGS, INC.","filed_at":"2023-01-23T23:59:59+00:00","discovered_at":"2026-05-14T18:03:45.542208+00:00","generated_at":"2026-06-20T11:46:26.313247+00:00","sec_items":["8.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Panacea Life Sciences signs LOI to acquire N7 Enterprises for 22.2M shares","bullets":["Panacea will issue 22.2 million common shares to N7 Enterprises stockholders.","N7 Enterprises had $4.1M revenue in FY2022 and estimated net income exceeding $1M.","Expected close on or around February 28, 2023, subject to due diligence and definitive agreement.","N7 operates Florida kava/kratom lounges (Lizard Juice, N7 Nitro Kava) and a distribution subsidiary."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-002132","json":"https://secwatch.observer/filing/0001493152-23-002132.json","markdown":"https://secwatch.observer/filing/0001493152-23-002132.md","text":"https://secwatch.observer/filing/0001493152-23-002132.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002132/0001493152-23-002132-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1552189/000149315223002132/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T11:46:26.313247+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}